The intent of this dissertation was to advance the knowledge of the impacts of building design and use on the quality of the potable water. Fluctuations in water use by occupants and equipment can cause stagnant conditions that causes water quality decay such as loss of chlorine disinfectant, an increase in microorganism and pathogen growth, an increase in metals concentrations, and an increase in disinfection byproducts. The United States Environmental Protection Agency has drinking water standards for distribution systems, but these standards stop at the meter with exception of the Lead and Copper Rule. There are also building codes to ensure proper plumbing materials are used that come in contact with potable water. However, neither standards nor codes require building water quality monitoring. Therefore, monitoring the building potable water system is an important aspect of building water quality that is not done on a large scale.Chapter 2 investigated how water quality evolved in a “green”, multi-story, institutional building during the first 6 months of building life. The results indicated that Wi-Fi logins could be used to correlate occupancy activity and copper (Cu) concentrations in water. As occupancy activity increased, Cu concentrations decreased. However, chlorine (Cl2) residual (or free chlorine) was only measurable twice at two kitchen sinks via grab sampling during the duration of the 6-month study regardless of occupancy activity. Chapter 3 provided improved understanding of how to carry out effective building water sampling (e.g., grab samples vs real time) and which water quality parameters were most influenced by the building water system during the first year of occupancy in relation to municipal water quality. The results showed the temperature (T), pH, UVA254, a surrogate for organic matter, cellular adenosine triphosphate (cATP), trihalomethanes (THMs), and Cu were always greater inside the building than at building entry while free Cl2 was always lower inside the building than at the building entry. Chapter 4 investigated a remedial flushing program for three schools. Overall, the study showed the quality of water does change after a flushing event. Free Cl2 was reestablished, and metals concentrations decreased. However, equipment flushing, such as hot water heaters, may be necessary to fully remediate Legionella. Lastly, one-time flushing is most likely a temporary solution. A more routine approach to building flushing and monitoring may be necessary until normal or sustained occupancy resumes.

Hepatitis C is an infectious disease that affects 71 million people worldwide and causes liver failure and death if untreated. In 2013, a direct acting antiviral drug, sofosbuvir, revolutionized treatment of the disease. Sofosbuvir showed immense promise, but the high price point at which it was launched created access barriers that prevented it from reaching its full public health potential. By 2016, fewer than 1% of Hepatitis C patients worldwide had received treatment. In the United States (US), concerns about the cost of the drug led public and private payers to implement rationing and treatment restrictions that prevented some of the most vulnerable populations from accessing Hepatitis C treatment at all. Through interviews with researchers, patients and providers, and a literature review of grants, patents, papers, court documents, and news articles, I examine the history of sofosbuvir with attention to the ways in which federal funding practices and intellectual property law encouraged the high initial pricing of the drug. I then examine the impact of this drug on healthcare systems in the United States and abroad, and discuss how the fragmented nature of the United States healthcare system has exacerbated price-based barriers to access. Finally, I discuss intellectual property laws as potential mechanisms to increase access. My study underscores how the political reluctance to use well-established federal funding and intellectual property laws has resulted in a drug development system that delivers medications that are so highly priced that the fragmented US healthcare system cannot compensate for the expense. This leads to low access and poor public health outcomes, and a continued failure to contain or control diseases for which effective therapies exist.

Atrial fibrillation (AF) is the most common abnormal heart rhythm, affecting

nearly 2% of the world’s population at a cost of $26 Billion in the United States annually, and incalculable costs worldwide. AF causes no symptoms for some people. However, others with AF experience uncomfortable symptoms including palpitations, breathlessness, dizziness, and fatigue. AF can severely diminish quality of life for both AF sufferers and their loved ones. Beyond uncomfortable symptoms, AF is also linked to congestive heart failure and stroke, both of which can cause premature death. Medications often fail to control AF, leading patients and healthcare providers to seek other cures, including catheter ablation. To date, catheter ablation has yielded uneven results, but garners much attention in research and innovation in pursuit of a cure for AF. This dissertation examines the historical development and contemporary practices of AF ablation to identify opportunities to improve the innovation system for the disease. First, I trace the history of AF and AF ablation knowledge from the 2nd century B.C.E. through the present. This historical look identifies patterns of knowledge co-development between science, technology, and technique, as well as publication patterns impacting knowledge dissemination. Second, I examine the current practices of AF ablation knowledge translation from the perspective of clinical practitioners to characterize the demand-side of knowledge translation in real-world practice. Demand-side knowledge translation occurs in nested patterns, and requires data, experience, and trust in order to incorporate knowledge into a practice paradigm. Third, I use social network mapping and analysis to represent the full AF ablation knowledge-practice system and identify

opportunities to modify research and innovation practice in AF ablation based on i

measures of centrality and power. Finally, I outline six linked recommendations using raw data capture during ablation procedures and open big data analytics, coupled with multi-stakeholder social networking approaches, to maximize innovation potential in AF ablation research and practice.